Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014:2014:480258.
doi: 10.1155/2014/480258. Epub 2014 May 27.

Antiartherosclerotic effects of plant flavonoids

Affiliations
Review

Antiartherosclerotic effects of plant flavonoids

Shamala Salvamani et al. Biomed Res Int. 2014.

Abstract

Atherosclerosis is the process of hardening and narrowing the arteries. Atherosclerosis is generally associated with cardiovascular diseases such as strokes, heart attacks, and peripheral vascular diseases. Since the usage of the synthetic drug, statins, leads to various side effects, the plants flavonoids with antiartherosclerotic activity gained much attention and were proven to reduce the risk of atherosclerosis in vitro and in vivo based on different animal models. The flavonoids compounds also exhibit lipid lowering effects and anti-inflammatory and antiatherogenic properties. The future development of flavonoids-based drugs is believed to provide significant effects on atherosclerosis and its related diseases. This paper discusses the antiatherosclerotic effects of selected plant flavonoids such as quercetin, kaempferol, myricetin, rutin, naringenin, catechin, fisetin, and gossypetin.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Margaret C. Burden: mortality, morbidity and risk factors. Global Status Report on Non Communicable Diseases. 2010
    1. Navab M, Berliner JA, Watson AD, et al. The Yin and Yang of oxidation in the development of the fatty streak. Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16(7):831–842. - PubMed
    1. Ross R. Atherosclerosis—an inflammatory disease. The New England Journal of Medicine. 1999;340(2):115–126. - PubMed
    1. Steinberg D, Witztum JL. In: Lipoproteins, Lipoprotein, Oxidation, and Atherogenesis. Chien KR, editor. Philadelphia, Pa, USA: WB Saunders; 1999.
    1. Keaney JF., Jr. Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction. Molecular Aspects of Medicine. 2000;21(4-5):99–166. - PubMed